With an emphasis on the protection and commercialization of academic inventions, the question of how to manage intellectual property is key, not only for university technology transfer offices (TTOs) but also for small and medium-sized enterprises (SMEs), and industries engaging in R&D for access to intellectual property complementary to their own R&D activities. The aim of this course is to raise awareness and understanding of intellectual property rights among early career stage researchers who are the professionals of tomorrow. Yet, the course is recommended for researchers at all career stages, and scientific support and management support personnel interested in this topic.
The Bellvitge Biomedical Research Institute (IDIBELL) is a research centre in biomedicine promoted by the Bellvitge University Hospital and l’Viladecans Hospital, both from the Catalan Health Institute, the Catalan Institute of Oncology, University of Barcelona and L’Hospitalet de Llobregat city council. In 2017, the Center for Regenerative Medicine of Barcelona (CMR[B]), now part of IDIBELL, launched the Program for Advancing the Clinical Translation of Regenerative Medicine of Catalonia (P-CMR[C]) together with IDIBELL.
IDIBELL research is focused in cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the axes on which researchers work every day with the goal of improving the quality of life of citizens.
IDIBELL is located in L’Hospitalet de Llobregat, south of Barcelona. It is a member of the Campus of International Excellence of the University of Barcelona (HUBc) and Research Centers of Catalonia (CERCA). In 2009, it became one of the first five Spanish research centres accredited as a health research institute by the Health Institute Carlos III. In 2015, the European Commission recognized IDIBELL with the ‘HR Excellence in Research’ award, which identifies IDIBELL as a provider and supporter of a stimulating research work environment.